Research Groups and R&D Platforms: Assay development
Research Group:
Digital DNA diagnostics for detection of antimicrobial resistant pathogens
Ari Lehmusvuori
artule[at]utu.fi
Department of Life Technologies,
University of Turku
Antibioottiresistenttien bakteerien nopea detektio digitaalisella DNA-sensoritekniikalla
Assay development, Biochemistry, Biotechnology, Cardiovascular diseases, Clinical Chemistry, Clinical Medicine, Genetics, Genomics, In Vitro Diagnostics, Infection, Molecular diagnostics, Molecular modelling, Nucleic acids
Research Group:
Systems Medicine
Matej Oresic
matej.oresic[at]utu.fi
Turku Bioscience Centre,
University of Turku
Assay development, Autoimmune diseases, Bioinformatics, Biomarker, Diabetes, Diagnostics, Metabolic diseases, Metabolomics, Molecular diagnostics, Obesity, Personalized medicine, Systems Biology
Research Group:
The in vitro/in vivo applications of hot electrons in clinical research and health care
Heikki Peuravuori
heipeu[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibacterial, Antibodies, Assay development, Bacteriology, Biochemistry, Biomarker, Biomedicine, Biotechnology, Chemical Physics, Clinical Chemistry, Electron microscopy, Fluorescence spectroscopy, Imaging software, Immunology, In Vitro Diagnostics, In Vivo Diagnostics, Medicinal chemistry, Point of care
Research Group:
Alpha2-Adrenoceptors as targets for drug development
Mika Scheinin
mschein[at]utu.fi
University of Turku, Turku University Hospital and CRST Oy
Clinical Research Services Turku
Ageing-related diseases, Allergy, Antibodies, Assay development, Asthma, Autoimmune diseases, Basic research, Biomarker, Biomedicine, Biopharmaceuticals, Cancer, Cardiovascular diseases, Clinical Medicine, Diabetes, Diagnostics, Disease models, Drug delivery, Drug target, Endocrinology, Imaging, In Vitro Diagnostics, In Vivo Diagnostics, Inflammation, Medicinal chemistry, Metabolic diseases, Metal disorders, Molecular diagnostics, Musculoskeletal disorders, Natural products, Neurological disorders, Obesity, Organic compounds, Personalized medicine, PET, Pharmacology, Receptor, Screening, Signaling, Skin diseases, Target discovery
Research Group:
Genetic predisposition to cancer
Johanna Schleutker
Johanna.Schleutker[at]utu.fi
Institute of Biomedicine,
University of Turku
Antibodies, Assay development, Bioinformatics, Biomarker, Biomedicine, Biotechnology, Breast cancer, Cancer, Clinical Medicine, Data mining, Diagnostics, Epidemiology, Genetics, Genomics, In Vitro Diagnostics, Inherited diseases, Machine learning, Molecular Biology, Molecular diagnostics, Next-generation sequencing, Personalized medicine, Point of care, Prostate cancer, Screening
Research Group:
High sensitivity multiplex point-of-care assay systems for the detection of blood borne infections in emergency settings (Indo-Finland joint project)
Kim Pettersson
kim.pettersson[at]utu.fi
Department of Life Technologies,
University of Turku
Antibodies, Assay development, Biomarker, Biotechnology, Electron microscopy, In Vitro Diagnostics, Infection, Nanoparticles, Virology
